3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
4
Ovarian Neoplasms
2
Triple Negative Breast Neoplasms
1
Metastatic Breast Cancer With a Isolated Brain Progression
1
Lymphoma
1
Hodgkin Disease
1
Interventions
tucatinib
1
pertuzumab
1
Trastuzumab
1
Biosimilar Pharmaceuticals
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Metastatic Breast Cancer With a Isolated Brain Progression
×
Biosimilar Pharmaceuticals
×
Clear all
NCT05041842
2025-11-17
InTTercePT
UNICANCER
Phase 2
Active not recruiting
53 enrolled